T cell receptor grafting allows virological control of hepatitis B virus infection

Karin Wisskirchen(Shanghai Cell Therapy Research Institute), Ulrike Protzer(German Center for Infection Research)
Journal of Clinical Investigation
April 30, 2019
10.1172/jci120228
Cited by 83

Related Papers

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV
|Nature|2021|734
Viral hepatitis and liver cancer
|Philosophical Transactions of the Royal Society B Biological Sciences|2017|412
New findings in HCV genotype distribution in selected West European, Russian and Israeli regions
|Journal of Clinical Virology|2016|73
Multi-proteomic profiling of the varicella-zoster virus–host interface reveals host susceptibilities to severe infection
|Nature Microbiology|2025|6